# A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-18 22:29 UTC · Category: Business · Sources: 6 · Current Velocity: 4.29

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Yahoo Finance | Amylyx Pharmaceuticals Phase 3 LUCIDITY Trial Meets Primary Endpoint for Avexitide | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPQnV2OXZyUVV0ZDFVeUstdHMweWVSd0o0TVZIN1Z0WHdxdldFNWdNQVMtUVd2ak1jcXFETWtHc2NINzh1Y3F0TVF1TUZTTzN3OXQxUEZlMmw5R2o0aGFtMzdPX1g4R242NjBMTm5lWGc3SlZrdlVoYlpxdThnMGRjeGNFX2hoRDl2eDE3ZjJqdHVZaWVLbXJHRkt4akZaaGRGblE?oc=5) |
| Endpoints News | Amylyx declares late-stage win with a GLP-1 antagonist in its post-ALS reset | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxPajZxV0JydENyN2Q3WUVTaUxsWDAwbV9wVVN5MlBQNTItcEZWUlhHMVl4Rm52Ylh5eXlyN0d0VjUxYzJQVzFFNDNmdkNSNldBSDU4VzFEWGVZdTVJNEtuSzJWZ1VHakdEMTN1VV9hODJoc0lOSXk1NllpRkFEcC1sU2ItOUJyNHd2U0xVaHUteURKVlIzOGdnVmtZeFROeFhqOTkzWDNZZFNaV0t5LVR0YjdR?oc=5) |
| statnews.com | Amylyx endocrine drug succeeds in pivotal study | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxNajAyS0NLemlxcHV5TVR2Ykc3VFlQSmhWVFBpaDF2d0VVZW1CbUVNSEN0MGVoVU1DcmtDbmJpcFNfVzc4YUlXV3Y0aWlsR2tyZHZ5ZE5TOGt1QzNNZWRzZ2xPMXlfUXZCT2V3MTJyTkdvZmRxMGx5SjYxTGNzdkctZHBnY0tpbzI0blN1aG9YOWN2dXZKY3lzajRjZFliVUlYc2NpREFjbTdzN2xjREgxb2NnRGZoYTRpOGU5Wk5n?oc=5) |
| Reuters | Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMi5AFBVV95cUxPX1pnM1VvNXlQNlJRcEg0dG5CZ3FYM2hValFUNHB3YWhrMDdVdzZhZmR0WUpBTVFWV1dXekFCQXZSZ3pxM1V4QVQyTk1Na1VNTHQtTC1qalBCVDJPZU5zdFhSa2JOd0JxaEQtNmJrX0xmQjlYNUc5R2t1RjdJZXJXQWt6dDFXSHB5cHZtS285enFjdXF5MnZKVUxSQmRzUFNieHlJUXlici1YUTY5TXJtdzFhNTV2Rk5LaUE0V0g2MmwxenhfZjVVdFFJUGtJVm84Nk5wOU4tWjhQLWNxV3Q4cDJTUVI?oc=5) |
| Yahoo Finance | Amylyx stock surges after avexitide Phase 3 trial success | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNbkgyOU1JZExSY2R0YmtzREpCSXdvV0ExMm41YXY3NGJTMGhJWi1PUWlBT3NYcDBPUllXak5uQmcxdUloMExvRjlqYUtlakFsSzRCN2U0M3NaNFJzeUhPUWJmRUZmR3hQVFc2NWZGd01tNWxJUWJOMG1ncV9tOTF1SFhCVmQ3aE1XRjZMV2ROd0RqalppcjVSUUg5dkg?oc=5) |
| Barron's | Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTFBtTVMyQk5MYUpwMHEwa29hWURIbk9lZmVJWjBCNFlNMkprNnVKYlhiSHBHVmYyVXQ0R19jZUIxM0d4a2RUQUNtRm9VcUJ0a2h3cmFqX0lneEpQWFl2YWVZZk1qeWs0V0pQalh2U2ZEcjMyQVkyYkM3ODd3VQ?oc=5) |
| Investor's Business Daily | A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High | 2026-08-18 14:20 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxOREZ6Ukg4dkZ1T1FqbExHV0pRbHZNYTZITDBHdlNuRVlRRmtoVmltTlhHeEVpMFZiRkYxU0lCYkdkUXNjUFF0Tmlhb0VTVjdzYW1pZkZfbUJ1ZV94WklUbkdfbU1Ja0I2VUlfUURRVU9paTF6VDU1NF9WcWxyNmswLXNGRXV1QTdYN09JS29SQWpRX3dQazBSeFBNSlFHU1RlSG5NMzNvTERvVXNENFEtYVdn?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-18/a-new-use-for-glp-1s-amylyx-pharma-catapults-to-3-year-high*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*